LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 49.56 | 21.74 | 2381 | 4838 | 0.4921 | 0.8262 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 49.56 | 21.74 | 33 | 4838 | 0.0068 | 0.0550 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 49.56 | 21.74 | 2189 | 4838 | 0.4524 | 0.8066 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 51.53 | 21.74 | 27 | 5150 | 0.0052 | 0.0279 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 51.53 | 21.74 | 2498 | 5150 | 0.4850 | 0.8247 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 51.53 | 21.74 | 28 | 5150 | 0.0054 | 0.0326 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 51.53 | 21.74 | 2303 | 5150 | 0.4471 | 0.8060 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 53.50 | 21.74 | 30 | 5425 | 0.0055 | 0.0413 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 53.50 | 21.74 | 2574 | 5425 | 0.4744 | 0.8212 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 53.50 | 21.74 | 42 | 5425 | 0.0077 | 0.0862 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 53.50 | 21.74 | 2425 | 5425 | 0.4469 | 0.8076 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 55.48 | 21.74 | 41 | 5768 | 0.0071 | 0.0820 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 55.48 | 21.74 | 2764 | 5768 | 0.4791 | 0.8253 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 55.48 | 21.74 | 32 | 5768 | 0.0055 | 0.0492 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 55.48 | 21.74 | 2587 | 5768 | 0.4485 | 0.8104 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 57.45 | 21.74 | 32 | 6023 | 0.0053 | 0.0488 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 57.45 | 21.74 | 2834 | 6023 | 0.4705 | 0.8225 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 57.45 | 21.74 | 42 | 6023 | 0.0070 | 0.0845 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 57.45 | 21.74 | 2769 | 6023 | 0.4597 | 0.8173 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 59.42 | 21.74 | 47 | 6125 | 0.0077 | 0.0994 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 59.42 | 21.74 | 3019 | 6125 | 0.4929 | 0.8335 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 59.42 | 21.74 | 50 | 6125 | 0.0082 | 0.1078 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 59.42 | 21.74 | 2876 | 6125 | 0.4695 | 0.8226 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 62.39 | 21.74 | 52 | 6112 | 0.0085 | 0.1132 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 62.39 | 21.74 | 3177 | 6112 | 0.5197 | 0.8454 | MN20160310_N01 | H17 |